Endometrial Sampling (Pipelle)in IVF Patients - Full Text View

Endometrial Sampling (Pipelle)in IVF Patients

This study is currently recruiting participants.
Verified by Sheba Medical Center, December 2006

Sponsored by:	Sheba Medical Center
Information provided by:	Sheba Medical Center
ClinicalTrials.gov Identifier:	NCT00411021

Purpose

A prospective cross-over randomized study aimed to test the hypothesis that local injury of the endometrium increases the implantation rate in the successive cycle. Seventy IVF patients will be randomly selected to undergo either endometrial biopsies or minimal cervical scratch on days 8-10 and 21-23 of their cycle, preceding the IVF treatment. If not pregnant, the women will continue for another IVF cycle, preceded by endometrial or cervical scratch complimentary to their procedure in the first cycle. The main major outcomes will include pregnancy rate, implantation rate, endometrial thickness, abortion rate, live births and embryo quality.

Condition	Intervention
Infertility	Procedure: Pipelle (Endometrial Sampling)

MedlinePlus related topics:

Infertility

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Crossover Assignment, Efficacy Study

Official Title:	Endometrial Sampling (Pipelle)in IVF Patients

Further study details as provided by Sheba Medical Center:

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	20 Years to 45 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Women undergoing IVF treatment
Repeated Implantation failure

Exclusion Criteria:

PID or suspected PID
Undiagnosed Irregular Bleeding

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00411021

Contacts


Contact: Micha Baum, MD		baumdr@zahav.net.il

Locations


Israel
	IVF Unit, Sheba Medical Center	Recruiting
	Ramat-Gan, Israel, 52621
	Contact: Micha Baum, MD baumdr@zahav.net.il

Sponsors and Collaborators

Sheba Medical Center

Investigators


Principal Investigator:	Micha Baum, MD	Sheba Medical Center, Israel

More Information

Study ID Numbers:	SHEBA-05-3674-MB-CTIL
First Received:	December 12, 2006
Last Updated:	December 12, 2006
ClinicalTrials.gov Identifier:	NCT00411021
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Study placed in the following topic categories:

Genital Diseases, Female

Infertility

Genital Diseases, Male

ClinicalTrials.gov processed this record on October 15, 2008